NCT07067151

Using Smartwatches to Monitor Smoking in Real-life Situations

Enrolling by Invitation
Not specifiedAges 21+Observational
National Institute on Minority Health and Health Disparities (NIMHD)
~30 participants
Updated 2026-08-03 on ClinicalTrials.gov

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
The primary endpoint is to evaluate changes in biomarker measurements obtained from wearables, which include heart rate, heart rate variability, respiratory rate, blood oxygen levels & hand/arm movement, across three smoking stages.
Measured over 7 days
Smoking
1 sites across 1 states
Kansas1
  • Sherine M El-Toukhy, Ph.D. · PRINCIPAL_INVESTIGATOR · National Institute on Minority Health and Health Disparities (NIMHD)

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

be 21 years or older in compliance with Tobacco 21 laws
have no college degree or be currently enrolled in college
have smoked 100 cigarettes in their lifetime and 5+ cigarettes per day in the past year to establish daily smoking status
willing to abstain from smoking for \>=12 hours prior to the lab visit verifiable by a CO reading that is below 10 ppm and retrospectively by minimal nicotine in blood sample
willing to abstain from using any nicotine products or devices for \>=12 hours prior to the lab visit
willing to abstain from alcohol use for \>=12 hours prior to the lab session verifiable by breath alcohol concentration (BrAC = 0.000)
willing to adhere to all study procedures including agreeing to a blood draw and bringing \>=1cigarette for use during the study visit
have a smartphone compatible with wearable device requirements for Bluetooth and operating system (iphone iOS 14 and higher, Android 9.0 and higher) and willing to download the study apps onto their phone
speak English
and willing and able to provide informed consent.

Exclusion

are not abstinent before the lab session through biochemical verification after two attempts
have sought treatment for tobacco/nicotine use in the past 2 months (e.g., on pharmacotherapy for smoking cessation, enrolled in smoking cessation support programs or interventions)
have past 3-month pulmonary or cardiovascular event, or those who have been hospitalized or visited the emergency room for seizure, stroke, or new heart problems,
are pregnant or breastfeeding
and are unable or unwilling to provide informed consent.
  • The primary endpoint is to evaluate changes in biomarker measurements obtained from wearables, which include heart rate, heart rate variability, respiratory rate, blood oxygen levels & hand/arm movement, across three smoking stages.7 days

    As the research progresses, the team will work diligently to gather a robust dataset from various sources, including wearable devices, lab sessions, medical-grade information, and detailed questionnaires. This comprehensive approach will enable the identification of specific biomarkers and hand-mouth gestures related to the different stages of tobacco use: pre-smoking, active smoking, and post-smoking. By analyzing these diverse data sources, the team aims to gain valuable insights into the physiological and behavioral patterns associated with each stage. This knowledge will not only enrich our understanding of tobacco use but also pave the way for developing targeted interventions and tailored support systems for individuals seeking to quit smoking. Through collaboration and innovative analysis, this research endeavors to create more effective strategies for smoking cessation, ultimately fostering healthier lifestyles.